ProShares UltraShort NASDAQ Biotechnology
3 hedge funds and large institutions have $671K invested in ProShares UltraShort NASDAQ Biotechnology in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
689% more capital inflows, than outflows
Capital inflows: $144K | Capital outflows: $18.3K
50% more funds holding
Funds holding: 2 → 3 (+1)
6.19% more ownership
Funds ownership: 30.1% → 36.29% (+6.2%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$138K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tower Research Capital (TRC)
New York
|
-$18.3K |
BIS Hedge Fund Activity: Q3 2026 in Review
3 of the 8,154 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort NASDAQ Biotechnology (BIS) for Q3 2026, worth a combined $671K — down 0.97% from $677K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIS positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $138K. The largest seller was Tower Research Capital (TRC), cutting an estimated $18.3K.
- 3 institutional investors held ProShares UltraShort NASDAQ Biotechnology (BIS) as of Q3 2026, up from 2 in Q2 2026.
- Funds reported $671K of ProShares UltraShort NASDAQ Biotechnology stock for Q3 2026, down 0.97% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort NASDAQ Biotechnology positions in Q3 2026 and 0 closed out, a net change of +1 holder.
- The largest ProShares UltraShort NASDAQ Biotechnology buyer in Q3 2026 was Susquehanna International Group, an estimated $138K added.
- The largest ProShares UltraShort NASDAQ Biotechnology seller in Q3 2026 was Tower Research Capital (TRC), an estimated $18.3K sold.
Based on aggregated 13F filings for Q3 2026.